Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress

Journal of Neuroscience Research

Volumn 87, Issue 11, 2009, Pages 2551-2560

  Schulte Herbrüggen, Olaf ^a   Fuchs, Eberhard ^b   Abumaria, Nashat ^b   Ziegler, Annerose ^a   Danker Hopfe, Heidi ^a   Hiemke, Christoph ^c   Hellweg, Rainer ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

BDNF; Depression; Escitalopram; NGF; Serum, body weight

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESCITALOPRAM; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN; ANTIDEPRESSANT AGENT; CITALOPRAM; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SOCIAL STRESS; WEIGHT GAIN; ADRENAL GLAND; ANIMAL; BLOOD; BRAIN; CHRONIC DISEASE; DRINKING BEHAVIOR; DRUG EFFECT; HEMISPHERIC DOMINANCE; MENTAL STRESS; METABOLISM; ORGAN SIZE; PATHOLOGY; SOCIAL DOMINANCE; STATISTICAL MODEL; WISTAR RAT;

ADRENAL GLANDS; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BODY WEIGHT; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC DISEASE; CITALOPRAM; DOMINANCE-SUBORDINATION; DRINKING BEHAVIOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL LATERALITY; LINEAR MODELS; MALE; NERVE GROWTH FACTOR; ORGAN SIZE; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 70349250240     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22080     Document Type: Article

References (85)

1. Abumaria N, Rygula R, Hiemke C, Fuchs E, Havemann-Reinecke U, Ruther E, Flugge G. 2007. Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat. Eur Neuropsychopharmacol 17:417-429. (Pubitemid 46497654)
2. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. 1994. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci USA 91:10440-10444. (Pubitemid 24329013)
3. Aydemir O, Deveci A, Taneli F. 2005. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29:261-265. (Pubitemid 40202912)
4. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, Goka E. 2006. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 30:1256-1260. (Pubitemid 44216065)
5. Barrientos RM, Sprunger DB, Campeau S, Higgins EA, Watkins LR, Rudy JW, Maier SF. 2003. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121:847-853. (Pubitemid 37324583)
6. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. 1992. The anatomy of melancholia - focal abnormalities of cerebral blood flow in major depression. Psychol Med 22:607-615.
7. Branchi I, D'Andrea I, Sietzema J, Fiore M, Aloe L, Alleva E. 2006. Early social enrichment augments adult hippocampal BDNF levels and survival of BrdU-positive cells while increasing anxiety- and "depression"-like behavior. J Neurosci Res 83:965-973.
8. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA. 2007. Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32:2351-2359. (Pubitemid 47587673)
9. Chen AC, Shirayama Y, Shin KH, Neve RL, Duman RS. 2001. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49:753-762. (Pubitemid 32452296)
10. Claasen V. 1994. Neglected factors in pharmacology and neuroscience research. In: Huston JP, editor. Techniques in the behavioral and neural sciences, vol 12. Amsterdam: Elsevier.
11. Coan JA, Allen JJ. 2004. Frontal EEG asymmetry as a moderator and mediator of emotion. Biol Psychol 67:7-49. (Pubitemid 38582072)
12. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. 1997. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-2313. (Pubitemid 27137397)
13. Coppell AL, Pei Q, Zetterstrom TS. 2003. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44:903-910. (Pubitemid 36515026)
14. Czeh B, Muller-Keuker JI, Rygula R, Abumaria N, Hiemke C, Domenici E, Fuchs E. 2007. Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 32:1490-1503. (Pubitemid 46920152)
15. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. 2003. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163:59-64. (Pubitemid 36091601)
16. Dalton SO, Sorensen HT, Johansen C. 2006. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs 20:143-151.
17. de Abajo FJ, Rodriguez LA, Montero D. 1999. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319:1106-1109. (Pubitemid 29494721)
18. de Abajo FJ, Montero D, Rodriguez LA, Madurga M. 2006. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 98:304-310.
19. De FG, Carney SL, Robinson CS, Destexhe EJ, Tomlinson R, Hicks CA, Murray TK, Gaillard JP, Deville C, Xhenseval V, Thomas CE, O'Neill MJ, Zetterstrom TS. 2004. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128:597-604. (Pubitemid 39277429)
20. Dias BG, Banerjee SB, Duman RS, Vaidya VA. 2003. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45:553-563.
21. Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127.
22. Dwivedi Y, Mondal AC, Rizavi HS, Conley RR. 2005. Suicide brain is associated with decreased expression of neurotrophins. Biol Psychiatry 58:315-324. (Pubitemid 41133625)
23. El-Gharbawy AH, dler-Wailes DC, Mirch MC, Theim KR, Ranzenhofer L, Tanofsky-Kraff M, Yanovski JA. 2006. Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab 91:3548-3552.
24. Foreman PJ, Taglialatela G, Angelucci L, Turner CP, Perez-Polo JR. 1993. Nerve growth factor and p75NGFR factor receptor mRNA change in rodent CNS following stress activation of the hypothalamopituitary-adrenocortical axis. J Neurosci Res 36:10-18. (Pubitemid 23260458)
25. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. 2005. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255:381-386. (Pubitemid 43029827)
26. Groves JO. 2007. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079-1088.
27. Halperin D, Reber G. 2007. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 9:47-59.
28. Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS, dler-Wailes DC, Sanford EL, Lacbawan FL, Uhl GR, Rennert OM, Yanovski JA. 2008. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med 359:918-927.
29. Hayley S, Poulter MO, Merali Z, Anisman H. 2005. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135:659-678. (Pubitemid 41407732)
30. Hecker S, Mesulam MM. 1994. Two types of cholinergic projections to the rat amygdala. Neuroscience 60:383-397. (Pubitemid 24175210)
31. Hellweg R, Hock C, Hartung HD. 1989. An improved rapid and highly sensitive enzyme immunoassay for nerve growth factor. Techniq J Methods Cell Mol Biol 1:43-48.
32. Hellweg R, Gericke CA, Jendroska K, Hartung HD, Cervos-Navarro J. 1998. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Int J Dev Neurosci 16:787-794. (Pubitemid 29151766)
33. Hellweg R, Lang UE, Nagel M, Baumgartner A. 2002. Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats. Mol Psychiatry 7:604-608. (Pubitemid 34888423)
34. Hellweg R, von Arnim CA, Buchner M, Huber R, Riepe MW. 2003. Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation. Exp Neurol 183:346-354. (Pubitemid 37205077)
35. Hellweg R, Lohmann P, Huber R, Kuhl A, Riepe MW. 2006. Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment. Learn Mem 13:63-71. (Pubitemid 43204397)
36. Hellweg R, Zueger M, Fink K, Hörtnagl H, Gass P. 2007. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol Dis 25:1-7. (Pubitemid 44773792)
37. Herman JP, Cullinan WE. 1997. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84. (Pubitemid 27050702)
38. Huang TL, Lee CT, Liu YL. 2007. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 42:521-525.
39. Jacobsen JP, Mork A. 2004. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 1024:183-192. (Pubitemid 39286729)
40. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. 2002. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148. (Pubitemid 34258493)
41. Kerr BJ, Bradbury EJ, Bennett DL, Trivedi PM, Dassan P, French J, Shelton DB, McMahon SB, Thompson SW. 1999. Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci 19:5138-5148. (Pubitemid 29270149)
42. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H. 1985. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 4:1389-1393.
43. Lang UE, Anders D, Danker-Hopfe H, Hellweg R. 2004a. Measurement of nerve growth factor serum concentration in a psychologically stressful situation in men. Stress 7:39-42. (Pubitemid 38470328)
44. Lang UE, Hellweg R, Gallinat J. 2004b. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29:795-798. (Pubitemid 38402487)
45. Lang UE, Jockers-Scherübl MC, Hellweg R. 2004c. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J Neural Transm 111:387-411.
46. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T, Kunz D, Gallinat J. 2005. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology 180:95-99. (Pubitemid 40897075)
47. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A. 1996. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19:514-520. (Pubitemid 26359871)
48. Lewin GR, Barde YA. 1996. Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
49. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC. 2005. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115-123. (Pubitemid 39600596)
50. Lommatzsch M, Hornych K, Zingler C, Schuff-Werner P, Hoppner J, Virchow JC. 2006. Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology 31:388-394. (Pubitemid 43261658)
51. Martinowich K, Lu B. 2007. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33:73-88.
52. Martinowich K, Manji H, Lu B. 2007. New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093. (Pubitemid 47339961)
53. McAllister AK, Katz LC, Lo DC. 1999. Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22:295-318.
54. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. 2004. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164:2367-2370.
55. Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JM, Landgraf R, Holsboer F. 1995. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 7:841-845.
56. Movig KL, Janssen MW, de Waal MJ, Kabel PJ, Leufkens HG, Egberts AC. 2003. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 163:2354-2358.
57. Muscat R, Willner P. 1992. Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev 16:507-517.
58. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
59. Nibuya M, Nestler EJ, Duman RS. 1996. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365-2372. (Pubitemid 26154346)
60. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. 1997. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-1322.
61. Owens MJ, Knight DL, Nemeroff CB. 2001. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50:345-350.
62. Phillips ML, Drevets WC, Rauch SL, Lane R. 2003. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 54:515-528. (Pubitemid 37289438)
63. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, Alagappan A, Bah MJ, Dawood MY, Shah JD, Mark B, Kendall N, Smith MA, Saviolakis GA, Meyerhoff JL. 2004. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res 1025:10-20. (Pubitemid 39349520)
64. Rao N. 2007. The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet 46:281-290.
65. Roceri M, Cirulli F, Pessina C, Peretto P, Racagni G, Riva MA. 2004. Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry 55:708-714. (Pubitemid 38376182)
66. Rotenberg VS. 2004. The peculiarity of the right-hemisphere function in depression: solving the paradoxes. Prog Neuropsychopharmacol Biol Psychiatry 28:1-13.
67. Russo-Neustadt A, Beard RC, Cotman CW. 1999. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21:679-682. (Pubitemid 29486636)
68. Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U. 2005. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav Brain Res 162:127-134. (Pubitemid 40731540)
69. Rygula R, Abumaria N, Domenici E, Hiemke C, Fuchs E. 2006a. Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats. Behav Brain Res 174:188-192. (Pubitemid 44397187)
70. Rygula R, Abumaria N, Flugge G, Hiemke C, Fuchs E, Ruther E, Havemann-Reinecke U. 2006b. Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav Pharmacol 17:19-29. (Pubitemid 43068381)
71. Rygula R, Abumaria N, Havemann-Reinecke U, Ruther E, Hiemke C, Zernig G, Fuchs E, Flugge G. 2008. Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam. Behav Pharmacol 19:183-196. (Pubitemid 351670399)
72. Sanchez C, Gruca P, Bien E, Papp M. 2003. R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety. Pharmacol Biochem Behav 75:903-907. (Pubitemid 37289476)
73. Sapolsky RM, Romero LM, Munck AU. 2000. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Rev 21:55-89.
74. Scaccianoce S, Lombardo K, Angelucci L. 2000. Nerve growth factor brain concentration and stress: changes depend on type of stressor and age. Int J Dev Neurosci 18:469-479. (Pubitemid 30243077)
75. Schulte-Herbrüggen O, Chourbaji S, Muller H, Danker-Hopfe H, Brandwein C, Gass P, Hellweg R. 2006. Differential regulation of nerve growth factor and brain-derived neurotrophic factor in a mouse model of learned helplessness. Exp Neurol 202:404-409. (Pubitemid 44711900)
76. Schulte-Herbrüggen O, Hellweg R, Chourbaji S, Ridder S, Brandwein C, Gass P, Hörtnagl H. 2007. Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression. Exp Neurol 204:307-316. (Pubitemid 46343725)
77. Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64:527-532.
78. Shaywitz AJ, Greenberg ME. 1999. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821-861.
79. Smith MA, Makino S, Kim SY, Kvetnansky R. 1995a. Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology 136:3743-3750.
80. Smith MA, Makino S, Kvetnansky R, Post RM. 1995b. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15:1768-1777.
81. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Tone S, Senba E. 1997. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 28:103-110. (Pubitemid 27267820)
82. Vinet J, Carra S, Blom JM, Brunello N, Barden N, Tascedda F. 2004. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology 47:1062-1069. (Pubitemid 39535845)
83. von Richthofen S, Lang UE, Hellweg R. 2003. Effects of different kinds of acute stress on nerve growth factor content in rat brain. Brain Res 987:207-213. (Pubitemid 37281435)
84. Xu H, Steven RJ, Li XM. 2003. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28:53-62.
85. Ziegenhorn AA, Schulte-Herbrüggen O, Danker-Hopfe H, Malbranc M, Hartung HD, Anders D, Lang UE, Steinhagen-Thiessen E, Schaub RT, Hellweg R. 2007. Serum neurotrophins - a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 52:1436-1445. (Pubitemid 47090171)